Status:
COMPLETED
Pediatric Penetrating Crohn's Disease
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Pediatric gastroenterology service, Toulouse University Hospital: Dr Breton
Adult gastroenterology service, Montpellier University Hospital: Dr Pineton de Chambrun
Conditions:
Pediatric Penetrating Crohn's Disease
Eligibility:
All Genders
Up to 18 years
Brief Summary
The incidence of Crohn's disease (CD) increased the last few years, especially in children, with 20% percent of CD patients diagnosed during childhood. The CD is a chronic disease without curative tre...
Detailed Description
This study is cross-sectional and is carrying out between 1995 and 2017 in two French tertiary referral centers (Montpellier, Toulouse) and EPIMAD registry which is currently the largest Inflammatory ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- patients diagnosed with CD who had underwent a B3 complication (intra-abdominal abscess, fistula, perforation, peritonitis, or phlegmon)
- Exclusion criteria:
- patient having isolated perineal disease, indeterminate colitis or with too much missing data were excluded
- patients refuse the use of medical data will be excluded.
Exclusion
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04119635
Start Date
September 1 2017
End Date
September 30 2018
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295